1 Study Coverage 1.1 Ophthalmic Therapeutic Drugs Revenue in Ophthalmic Therapeutic Drugs Business (2017-2022) & (US$ Million) Introduction 1.2 Global Ophthalmic Therapeutic Drugs Outlook 2017 VS 2022 VS 2028 1.2.1 Global Ophthalmic Therapeutic Drugs Market Size for the Year 2017-2028 1.2.2 Global Ophthalmic Therapeutic Drugs Market Size for the Year 2017-2028 1.3 Ophthalmic Therapeutic Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States Ophthalmic Therapeutic Drugs in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of Ophthalmic Therapeutic Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 Ophthalmic Therapeutic Drugs Market Dynamics 1.4.1 Ophthalmic Therapeutic Drugs Industry Trends 1.4.2 Ophthalmic Therapeutic Drugs Market Drivers 1.4.3 Ophthalmic Therapeutic Drugs Market Challenges 1.4.4 Ophthalmic Therapeutic Drugs Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 Ophthalmic Therapeutic Drugs by Type 2.1 Ophthalmic Therapeutic Drugs Market Segment by Type 2.1.1 Anti-inflammatory Drugs 2.1.2 Anti-infective Drugs 2.1.3 Anti-glaucoma Drugs 2.1.4 Anti-allergy Drugs 2.1.5 Anti-VEGF Agents 2.1.6 Others 2.2 Global Ophthalmic Therapeutic Drugs Market Size by Type (2017, 2022 & 2028) 2.3 Global Ophthalmic Therapeutic Drugs Market Size by Type (2017-2028) 2.4 United States Ophthalmic Therapeutic Drugs Market Size by Type (2017, 2022 & 2028) 2.5 United States Ophthalmic Therapeutic Drugs Market Size by Type (2017-2028) 3 Ophthalmic Therapeutic Drugs by Application 3.1 Ophthalmic Therapeutic Drugs Market Segment by Application 3.1.1 Hospital Pharmacies 3.1.2 Online Pharmacies 3.1.3 Independent Pharmacies & Drug Stores 3.2 Global Ophthalmic Therapeutic Drugs Market Size by Application (2017, 2022 & 2028) 3.3 Global Ophthalmic Therapeutic Drugs Market Size by Application (2017-2028) 3.4 United States Ophthalmic Therapeutic Drugs Market Size by Application (2017, 2022 & 2028) 3.5 United States Ophthalmic Therapeutic Drugs Market Size by Application (2017-2028) 4 Global Ophthalmic Therapeutic Drugs Competitor Landscape by Company 4.1 Global Ophthalmic Therapeutic Drugs Market Size by Company 4.1.1 Top Global Ophthalmic Therapeutic Drugs Companies Ranked by Revenue (2021) 4.1.2 Global Ophthalmic Therapeutic Drugs Revenue by Player (2017-2022) 4.2 Global Ophthalmic Therapeutic Drugs Concentration Ratio (CR) 4.2.1 Ophthalmic Therapeutic Drugs Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of Ophthalmic Therapeutic Drugs in 2021 4.2.3 Global Ophthalmic Therapeutic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Ophthalmic Therapeutic Drugs Headquarters, Revenue in Ophthalmic Therapeutic Drugs Business (2017-2022) & (US$ Million) Type 4.3.1 Global Ophthalmic Therapeutic Drugs Headquarters and Area Served 4.3.2 Global Ophthalmic Therapeutic Drugs Companies Revenue in Ophthalmic Therapeutic Drugs Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into Ophthalmic Therapeutic Drugs Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States Ophthalmic Therapeutic Drugs Market Size by Company 4.5.1 Top Ophthalmic Therapeutic Drugs Players in United States, Ranked by Revenue (2021) 4.5.2 United States Ophthalmic Therapeutic Drugs Revenue by Players (2020, 2021 & 2022) 5 Global Ophthalmic Therapeutic Drugs Market Size by Region 5.1 Global Ophthalmic Therapeutic Drugs Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Ophthalmic Therapeutic Drugs Market Size by Region (2017-2028) 5.2.1 Global Ophthalmic Therapeutic Drugs Market Size by Region: 2017-2022 5.2.2 Global Ophthalmic Therapeutic Drugs Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Ophthalmic Therapeutic Drugs Market Size YoY Growth 2017-2028 6.1.2 North America Ophthalmic Therapeutic Drugs Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Ophthalmic Therapeutic Drugs Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Ophthalmic Therapeutic Drugs Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 China Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.3 Europe 6.3.1 Europe Ophthalmic Therapeutic Drugs Market Size YoY Growth 2017-2028 6.3.2 Europe Ophthalmic Therapeutic Drugs Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Ophthalmic Therapeutic Drugs Market Size YoY Growth 2017-2028 6.4.2 Latin America Ophthalmic Therapeutic Drugs Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Ophthalmic Therapeutic Drugs Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Ophthalmic Therapeutic Drugs Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 UAE 7 Company Profiles 7.1 Bayer 7.1.1 Bayer Company Details 7.1.2 Bayer Business Overview 7.1.3 Bayer Ophthalmic Therapeutic Drugs Introduction 7.1.4 Bayer Revenue in Ophthalmic Therapeutic Drugs Business (2017-2022) 7.1.5 Bayer Recent Development 7.2 Pfizer 7.2.1 Pfizer Company Details 7.2.2 Pfizer Business Overview 7.2.3 Pfizer Ophthalmic Therapeutic Drugs Introduction 7.2.4 Pfizer Revenue in Ophthalmic Therapeutic Drugs Business (2017-2022) 7.2.5 Pfizer Recent Development 7.3 Novartis 7.3.1 Novartis Company Details 7.3.2 Novartis Business Overview 7.3.3 Novartis Ophthalmic Therapeutic Drugs Introduction 7.3.4 Novartis Revenue in Ophthalmic Therapeutic Drugs Business (2017-2022) 7.3.5 Novartis Recent Development 7.4 ALLERGAN 7.4.1 ALLERGAN Company Details 7.4.2 ALLERGAN Business Overview 7.4.3 ALLERGAN Ophthalmic Therapeutic Drugs Introduction 7.4.4 ALLERGAN Revenue in Ophthalmic Therapeutic Drugs Business (2017-2022) 7.4.5 ALLERGAN Recent Development 7.5 Aerie Pharmaceuticals 7.5.1 Aerie Pharmaceuticals Company Details 7.5.2 Aerie Pharmaceuticals Business Overview 7.5.3 Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Introduction 7.5.4 Aerie Pharmaceuticals Revenue in Ophthalmic Therapeutic Drugs Business (2017-2022) 7.5.5 Aerie Pharmaceuticals Recent Development 7.6 Bausch Health 7.6.1 Bausch Health Company Details 7.6.2 Bausch Health Business Overview 7.6.3 Bausch Health Ophthalmic Therapeutic Drugs Introduction 7.6.4 Bausch Health Revenue in Ophthalmic Therapeutic Drugs Business (2017-2022) 7.6.5 Bausch Health Recent Development 7.7 Genentech 7.7.1 Genentech Company Details 7.7.2 Genentech Business Overview 7.7.3 Genentech Ophthalmic Therapeutic Drugs Introduction 7.7.4 Genentech Revenue in Ophthalmic Therapeutic Drugs Business (2017-2022) 7.7.5 Genentech Recent Development 7.8 Regeneron Pharmaceuticals 7.8.1 Regeneron Pharmaceuticals Company Details 7.8.2 Regeneron Pharmaceuticals Business Overview 7.8.3 Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Introduction 7.8.4 Regeneron Pharmaceuticals Revenue in Ophthalmic Therapeutic Drugs Business (2017-2022) 7.8.5 Regeneron Pharmaceuticals Recent Development 7.9 Takeda 7.9.1 Takeda Company Details 7.9.2 Takeda Business Overview 7.9.3 Takeda Ophthalmic Therapeutic Drugs Introduction 7.9.4 Takeda Revenue in Ophthalmic Therapeutic Drugs Business (2017-2022) 7.9.5 Takeda Recent Development 7.10 Santen Pharmaceutical 7.10.1 Santen Pharmaceutical Company Details 7.10.2 Santen Pharmaceutical Business Overview 7.10.3 Santen Pharmaceutical Ophthalmic Therapeutic Drugs Introduction 7.10.4 Santen Pharmaceutical Revenue in Ophthalmic Therapeutic Drugs Business (2017-2022) 7.10.5 Santen Pharmaceutical Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer

List of Tables Table 1. Ophthalmic Therapeutic Drugs Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Ophthalmic Therapeutic Drugs Market Trends Table 3. Ophthalmic Therapeutic Drugs Market Drivers Table 4. Ophthalmic Therapeutic Drugs Market Challenges Table 5. Ophthalmic Therapeutic Drugs Market Restraints Table 6. Global Ophthalmic Therapeutic Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Ophthalmic Therapeutic Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Ophthalmic Therapeutic Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Ophthalmic Therapeutic Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Ophthalmic Therapeutic Drugs Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Ophthalmic Therapeutic Drugs Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Ophthalmic Therapeutic Drugs Revenue Share by Player, 2017-2022 Table 13. Global Ophthalmic Therapeutic Drugs Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Ophthalmic Therapeutic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmic Therapeutic Drugs as of 2021) Table 15. Top Players of Ophthalmic Therapeutic Drugs in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Ophthalmic Therapeutic Drugs Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Ophthalmic Therapeutic Drugs Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Ophthalmic Therapeutic Drugs Players in United States Market, Ranking by Revenue (2021) Table 20. United States Ophthalmic Therapeutic Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Ophthalmic Therapeutic Drugs Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Ophthalmic Therapeutic Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Ophthalmic Therapeutic Drugs Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Ophthalmic Therapeutic Drugs Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Ophthalmic Therapeutic Drugs Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Ophthalmic Therapeutic Drugs Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Ophthalmic Therapeutic Drugs Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Ophthalmic Therapeutic Drugs Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Ophthalmic Therapeutic Drugs Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Bayer Company Details Table 31. Bayer Business Overview Table 32. Bayer Ophthalmic Therapeutic Drugs Product Table 33. Bayer Revenue in Ophthalmic Therapeutic Drugs Business (2017-2022) & (US$ Million) Table 34. Bayer Recent Development Table 35. Pfizer Company Details Table 36. Pfizer Business Overview Table 37. Pfizer Ophthalmic Therapeutic Drugs Product Table 38. Pfizer Revenue in Ophthalmic Therapeutic Drugs Business (2017-2022) & (US$ Million) Table 39. Pfizer Recent Development Table 40. Novartis Company Details Table 41. Novartis Business Overview Table 42. Novartis Ophthalmic Therapeutic Drugs Product Table 43. Novartis Revenue in Ophthalmic Therapeutic Drugs Business (2017-2022) & (US$ Million) Table 44. Novartis Recent Development Table 45. ALLERGAN Company Details Table 46. ALLERGAN Business Overview Table 47. ALLERGAN Ophthalmic Therapeutic Drugs Product Table 48. ALLERGAN Revenue in Ophthalmic Therapeutic Drugs Business (2017-2022) & (US$ Million) Table 49. ALLERGAN Recent Development Table 50. Aerie Pharmaceuticals Company Details Table 51. Aerie Pharmaceuticals Business Overview Table 52. Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Product Table 53. Aerie Pharmaceuticals Revenue in Ophthalmic Therapeutic Drugs Business (2017-2022) & (US$ Million) Table 54. Aerie Pharmaceuticals Recent Development Table 55. Bausch Health Company Details Table 56. Bausch Health Business Overview Table 57. Bausch Health Ophthalmic Therapeutic Drugs Product Table 58. Bausch Health Revenue in Ophthalmic Therapeutic Drugs Business (2017-2022) & (US$ Million) Table 59. Bausch Health Recent Development Table 60. Genentech Company Details Table 61. Genentech Business Overview Table 62. Genentech Ophthalmic Therapeutic Drugs Product Table 63. Genentech Revenue in Ophthalmic Therapeutic Drugs Business (2017-2022) & (US$ Million) Table 64. Genentech Recent Development Table 65. Regeneron Pharmaceuticals Company Details Table 66. Regeneron Pharmaceuticals Business Overview Table 67. Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Product Table 68. Regeneron Pharmaceuticals Revenue in Ophthalmic Therapeutic Drugs Business (2017-2022) & (US$ Million) Table 69. Regeneron Pharmaceuticals Recent Development Table 70. Takeda Company Details Table 71. Takeda Business Overview Table 72. Takeda Ophthalmic Therapeutic Drugs Product Table 73. Takeda Revenue in Ophthalmic Therapeutic Drugs Business (2017-2022) & (US$ Million) Table 74. Takeda Recent Development Table 75. Santen Pharmaceutical Company Details Table 76. Santen Pharmaceutical Business Overview Table 77. Santen Pharmaceutical Ophthalmic Therapeutic Drugs Product Table 78. Santen Pharmaceutical Revenue in Ophthalmic Therapeutic Drugs Business (2017-2022) & (US$ Million) Table 79. Santen Pharmaceutical Recent Development Table 80. Research Programs/Design for This Report Table 81. Key Data Information from Secondary Sources Table 82. Key Data Information from Primary Sources List of Figures Figure 1. Ophthalmic Therapeutic Drugs Product Picture Figure 2. Global Ophthalmic Therapeutic Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Ophthalmic Therapeutic Drugs Market Size 2017-2028 (US$ Million) Figure 4. United States Ophthalmic Therapeutic Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Ophthalmic Therapeutic Drugs Market Size 2017-2028 (US$ Million) Figure 6. United States Ophthalmic Therapeutic Drugs Market Share in Global 2017-2028 Figure 7. Ophthalmic Therapeutic Drugs Report Years Considered Figure 8. Product Picture of Anti-inflammatory Drugs Figure 9. Product Picture of Anti-infective Drugs Figure 10. Product Picture of Anti-glaucoma Drugs Figure 11. Product Picture of Anti-allergy Drugs Figure 12. Product Picture of Anti-VEGF Agents Figure 13. Product Picture of Others Figure 14. Global Ophthalmic Therapeutic Drugs Market Share by Type in 2022 & 2028 Figure 15. Global Ophthalmic Therapeutic Drugs Market Size by Type (2017-2028) & (US$ Million) Figure 16. Global Ophthalmic Therapeutic Drugs Market Share by Type (2017-2028) Figure 17. United States Ophthalmic Therapeutic Drugs Market Share by Type in 2022 & 2028 Figure 18. United States Ophthalmic Therapeutic Drugs Market Size by Type (2017-2028) & (US$ Million) Figure 19. United States Ophthalmic Therapeutic Drugs Market Share by Type (2017-2028) Figure 20. Product Picture of Hospital Pharmacies Figure 21. Product Picture of Online Pharmacies Figure 22. Product Picture of Independent Pharmacies & Drug Stores Figure 23. Global Ophthalmic Therapeutic Drugs Market Share by Application in 2022 & 2028 Figure 24. Global Ophthalmic Therapeutic Drugs Market Size by Application (2017-2028) & (US$ Million) Figure 25. Global Ophthalmic Therapeutic Drugs Market Share by Application (2017-2028) Figure 26. United States Ophthalmic Therapeutic Drugs Market Share by Application in 2022 & 2028 Figure 27. United States Ophthalmic Therapeutic Drugs Market Size by Application (2017-2028) & (US$ Million) Figure 28. United States Ophthalmic Therapeutic Drugs Market Share by Application (2017-2028) Figure 29. North America Ophthalmic Therapeutic Drugs Market Size Growth Rate 2017-2028 (US$ Million) Figure 30. U.S. Ophthalmic Therapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 31. Canada Ophthalmic Therapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 32. Europe Ophthalmic Therapeutic Drugs Market Size Growth Rate 2017-2028 (US$ Million) Figure 33. Germany Ophthalmic Therapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. France Ophthalmic Therapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 35. U.K. Ophthalmic Therapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 36. Italy Ophthalmic Therapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 37. Russia Ophthalmic Therapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 38. Asia-Pacific Ophthalmic Therapeutic Drugs Market Size Growth Rate 2017-2028 (US$ Million) Figure 39. China Ophthalmic Therapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. Japan Ophthalmic Therapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. South Korea Ophthalmic Therapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. India Ophthalmic Therapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. Australia Ophthalmic Therapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. China Taiwan Ophthalmic Therapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Indonesia Ophthalmic Therapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 46. Thailand Ophthalmic Therapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 47. Malaysia Ophthalmic Therapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Latin America Ophthalmic Therapeutic Drugs Market Size Growth Rate 2017-2028 (US$ Million) Figure 49. Mexico Ophthalmic Therapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 50. Brazil Ophthalmic Therapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 51. Argentina Ophthalmic Therapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 52. Middle East & Africa Ophthalmic Therapeutic Drugs Market Size Growth Rate 2017-2028 (US$ Million) Figure 53. Turkey Ophthalmic Therapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 54. Saudi Arabia Ophthalmic Therapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 55. UAE Ophthalmic Therapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 56. Bayer Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2017-2022) Figure 57. Pfizer Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2017-2022) Figure 58. Novartis Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2017-2022) Figure 59. ALLERGAN Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2017-2022) Figure 60. Aerie Pharmaceuticals Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2017-2022) Figure 61. Bausch Health Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2017-2022) Figure 62. Genentech Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2017-2022) Figure 63. Regeneron Pharmaceuticals Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2017-2022) Figure 64. Takeda Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2017-2022) Figure 65. Santen Pharmaceutical Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2017-2022) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

Bayer Pfizer Novartis ALLERGAN Aerie Pharmaceuticals Bausch Health Genentech Regeneron Pharmaceuticals Takeda Santen Pharmaceutical